RT doctoral thesis T1 Gene regulatory networks in parkinson's disease A1 Barba Reyes, Juan Manuel A2 Neurociencias AB Parkinson's disease (PD) has historically been understood as a primarily neuronal disorder, butgrowing evidence makes clear that glial cell dysfunction plays an active role in drivingneurodegeneration. This doctoral thesis presents a high-resolution transcriptomic and spatial atlas ofglial cells in the human dorsal striatum, covering both caudate nucleus and putamen, with the aim ofdeciphering their contribution to PD pathogenesis. By combining single-nucleus RNA sequencing(snRNA-seq) with image-based spatial transcriptomics (Xenium platform), we analyzed postmortemsamples from 56 donors (36 with PD and 20 neurologically healthy controls), profiling over 270,000glial nuclei.The analysis revealed a profound pathological remodeling across all three major glial lineages. Inoligodendrocytes, which represent the most abundant glial population, we identified 15transcriptionally distinct subpopulations, among which several disease-specific states emerged(PDAO-1, PDAO-2, PDAO-3, and PDAOPCs). These disease-associated states change theirhomeostatic myelinating function in favor of survival under proteostatic stress, as reflected by strongupregulation of heat shock proteins. This functional deviation disrupts normal maturation trajectories,collapses the adhesion signaling required for axonal contact, and correlates directly with alterations inmyelination, as demonstrated by reduced MBP immunoreactivity in striatal tissue. In astrocytes andmicroglia, the results are equally striking. The homeostatic astrocyte population (A0) declines in favorof two divergent reactive phenotypes in PD patients: AR1, defined by proteostatic stress adaptation,and AR2, characterized by overt neuroinflammation and metabolic stress. In parallel, microglia shiftaway from their homeostatic surveillance state (MH) toward disease-associated phenotypes includingphagocytically and metabolically exhausted DAM cells, markedly pro-inflammatory M1 states, and aheat-shock-protein-enriched stress phenotype (MH-HSP).Perhaps the most conceptually significant finding concerns how this cellular remodeling unfoldsacross disease progression. Stratification by Braak Lewy body stage revealed that PD does not followa single glial pathological trajectory. Instead, the data point to the existence of two mutually exclusivereactive programs across patients: an inflammatory/reactive program, dominated by AR2 astrocytesand M1 microglia, and a proteostatic stress program defined by the unfolded protein response (UPR),with predominance of AR1 astrocytes, MH-HSP microglia, and PDAO oligodendrocytes. Differentsubjects appear to engage preferentially one or the other of these programs, which challenges thetraditional view of PD as a disease with a single, uniform glial progression.Taken together, this thesis demonstrates that PD triggers a coordinated dysfunction of the entire glialnetwork in the dorsal striatum, altering cells that should be protective into amplifiers of tissuedamage. The identification of two clearly distinct glial profiles (reactive and UPR programs) reframesour understanding of neurodegeneration at the cellular level. Beyond that, it lays the conceptualgroundwork for future patient stratification based on biofluid biomarkers, opening a realistic pathtoward personalized therapeutic strategies that could modify disease course by targeting the specificglial dysfunctions driving each patient's pathology. YR 2026 FD 2026 LK http://hdl.handle.net/10498/40566 UL http://hdl.handle.net/10498/40566 LA eng DS Repositorio Institucional de la Universidad de Cádiz RD 18-nov-2026